drugset / Trial / NCT03134443

Evaluate the Efficacy and Safety of Andrographolide Sulfonate in Patients With Acute Tonsillitis

NCT03134443

Phase 4 Unknown 144 enrolled Jiangxi Qingfeng Pharmaceutical Co. Ltd.
RandomizedParallel-groupSingle-blindTreatment

Summary

A multicenter, randomized, single-blind, placebo-controlled,phase 4 clinical trial to evaluate the efficacy and safety of andrographolide sulfonate in patients with acute tonsillitis

Timeline

Start
2016-12-01
Primary completion
2017-12-31
Completion
2018-06-01

Drugs

EvaluationDrugModalityDoseRoute
Comparator andrographolide sulfonate Unknown 10 ml Intravenous
Comparator andrographolide sulfonate Unknown 20 ml Intravenous

Indications